Guglielmini, P., Serao, A., Zai, S., Piovano, P. and Grosso, F. (2015) “Second-line treatment with Axitinib: an effective and well-tolerated weapon in the therapeutic sequence of clear cell renal cell carcinoma”, Working Paper of Public Health, 4(1). doi: 10.4081/wpph.2015.6697.